Medicare will require hospitals to post prices online

April 25, 2018 by Ricardo Alonso-Zaldivar

Medicare will require hospitals to post their standard prices online and make electronic medical records more readily available to patients, officials said Tuesday.

The program is also starting a comprehensive review of how it will pay for costly new forms of immunotherapy to battle cancer.

Seema Verma, head of the Centers for Medicare and Medicaid Services, said the new requirement for online prices reflects the Trump administration's ongoing efforts to encourage patients to become better-educated decision makers in their own care.

"We are just beginning on price transparency," said Verma. "We know that hospitals have this information and we're asking them to post what they have online."

Hospitals are required to disclose prices publicly, but the latest change would put that information online in machine-readable format that can be easily processed by computers. It may still prove to be confusing to consumers, since standard rates are like list and don't reflect what insurers and government programs pay.

Patients concerned about their potential out-of-pocket costs from a hospitalization would still be advised to consult with their insurer. Most insurance plans nowadays have an annual limit on how much patients must pay in copays and deductibles—although traditional Medicare does not.

Likewise, many already make computerized records available to patients, but starting in 2021 Medicare would base part of a hospital's payments on how good a job they do.

Using remains a cumbersome task, and the Trump administration has invited technology companies to design secure apps that would let access their records from all their providers instead of having to go to different portals.

Verma also announced Medicare is starting a comprehensive review of how it will pay for a costly new form of immunotherapy called CAR-T. It's gene therapy that turbocharges a patient's own immune system cells to attack cancer.

Immune system T cells are filtered from the patient's own blood and reprogrammed to target and kill cancer cells that had managed to evade them. Hundreds of millions of copies of the revved-up are then returned to the patient's blood to take on the .

Though only a couple of such treatments have been approved for blood cancers, the cost can exceed $370,000 per patient.

"It's a new area for the agency," said Verma. "We haven't seen drugs priced at this level and we're having to think about our strategy."

Explore further: White House wants user-friendly electronic health records

Related Stories

White House wants user-friendly electronic health records

March 6, 2018
The Trump administration Tuesday launched a new effort under the direction of presidential son-in-law Jared Kushner to overcome years of problems with electronic medical records and make them easier for patients to use.

Hospital charges for outpatient cancer care highly variable, Medicare billing records show

February 20, 2018
An analysis of recent Medicare billing records for more than 3,000 hospitals across the United States shows that charges for outpatient oncology services such as chemo infusion or radiation treatment vary widely and exceed ...

Most health care records now are electronic

July 17, 2013
An ever-expanding amount of the nation's medical records—millions of prescriptions, medical reports and appointment reminders—are now computerized and part of an ambitious electronic medical records program, the Obama ...

Medicare sets new patient safety goals for hospitals

September 29, 2016
Medicare is setting new goals for keeping hospitalized patients safe and reducing readmissions after patients are discharged.

US regulators approve 2nd gene therapy for blood cancer

October 19, 2017
U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.

Many hospitals being penalized for 30-day readmissions

August 7, 2015
(HealthDay)—About half of the nation's hospitals are being penalized by Medicare for having patients return within a month of discharge, losing a combined $420 million, according to a report published by Kaiser Health.

Recommended for you

Phantom odors: One American in 15 smells odors that aren't there, study finds

August 16, 2018
Imagine the foul smell of an ash tray or burning hair. Now imagine if these kinds of smells were present in your life, but without a source. A new study finds that 1 in 15 Americans (or 6.5 percent) over the age of 40 experiences ...

US drug overdose deaths surge amid fentanyl scourge

August 16, 2018
US drug overdose deaths surged to nearly 72,000 last year, as addicts increasingly turn to extremely powerful synthetic opioid fentanyl as the supply of prescription painkillers has tightened.

Widespread declines in life expectancy across high income countries coincide with rising young adult, midlife mortality

August 15, 2018
The ongoing opioid epidemic in the United States is a key contributor to the most recent declines in life expectancy, suggests a study published by The BMJ today.

Parental life span predicts daughters living to 90 without chronic disease or disability

August 15, 2018
Researchers at the University of California San Diego School of Medicine report that women whose mothers lived to at least age 90 were more likely to also live to 90, free of serious diseases and disabilities.

Diets high in vegetables and fish may lower risk of multiple sclerosis

August 15, 2018
People who consume a diet high in vegetables and fish may have a reduced risk of multiple sclerosis, new research led by Curtin University has found.

Can sleeping too much lead to an early death?

August 15, 2018
A recent study in the Journal of the American Heart Association has led to headlines that will make you rethink your Saturday morning sleep in.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.